Security AgreementSecurity Agreement • May 1st, 2023 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledMay 1st, 2023 Company Industry JurisdictionThis Security Agreement (this “Agreement”), dated as of April 26, 2023, is executed by Aridis Pharmaceuticals, Inc., a Delaware corporation (“ARDS Inc.”), Aridis Biopharmaceuticals, LLC, a Delaware limited liability company (“ARDS LLC”), and Aridis Pharmaceuticals, C.V., a Netherlands partnership (“ARDS CV,” and together with ARDS Inc. and ARDS LLC, “Debtor”), in favor of Streeterville Capital, LLC, a Utah limited liability company (“Secured Party”).
Note Purchase And Loan Restructuring AgreementNote Purchase and Loan Restructuring Agreement • May 1st, 2023 • Aridis Pharmaceuticals, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledMay 1st, 2023 Company Industry JurisdictionThis Note Purchase and Loan Restructuring Agreement (this “Agreement”), dated as of April 26, 2023, is entered into by and among Aridis Pharmaceuticals, Inc., a Delaware corporation (“ARDS Inc.”), Aridis Biopharmaceuticals, LLC, a Delaware limited liability company (“ARDS LLC”), Aridis Pharmaceuticals, C.V., a Netherlands partnership (“ARDS CV,” and together with ARDS Inc. and ARDS LLC, “Company”), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).